McCleary Nadine J, Haakenstad Ellana K, Cleveland Jessica L F, Manni Michael, Hassett Michael J, Schrag Deb
Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Information & Analytics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
JAMIA Open. 2022 Jul 26;5(3):ooac064. doi: 10.1093/jamiaopen/ooac064. eCollection 2022 Oct.
As part of ongoing implementation of electronic patient-reported outcome tools at the Dana-Farber Cancer Institute, here we describe the development of the electronic New Patient Intake Questionnaire.
The original New Patient Intake Questionnaire includes a review of symptoms, oncology history, family history, health behaviors, health and social status, health literacy and numeracy, which was modified for integration into the EHR using content determination, build and configuration, implementation, analytics, and interventions. The engagement of key stakeholders, including patients, clinical staff, and providers, throughout the development and deployment of the electronic Questionnaire was crucial to producing a successful tool. Continual modifications based on input of stakeholders (such as mode of tool deployment) were made to ensure the utility and usability of the tool for both patients and providers.
Implementation of the EHR-integrated electronic New Patient Intake Questionnaire improved collection of the PRD by increasing questionnaire accessibility for patients, while also providing all available data to clinicians and researchers. Careful consideration of the content and configuration of the questionnaire allowed for a successful, institute-wide implementation of the tool.
This effort demonstrates the feasibility of implementation of a system-wide electronic questionnaire, emphasizing the importance of iterative refinement to create a tool that is both patient-centric and usable for clinicians.
The electronic New Patient Intake Questionnaire allows for systematic collection of the PRD, which should benefit cancer care outcomes through innovative care delivery and healthcare interventions.
作为丹娜法伯癌症研究所持续实施电子患者报告结局工具的一部分,我们在此描述电子新患者入院调查问卷的开发过程。
原始的新患者入院调查问卷包括对症状、肿瘤病史、家族病史、健康行为、健康与社会状况、健康素养和算术能力的回顾,通过内容确定、构建与配置、实施、分析和干预对其进行修改,以整合到电子健康记录(EHR)中。在电子调查问卷的整个开发和部署过程中,关键利益相关者(包括患者、临床工作人员和医疗服务提供者)的参与对于打造一个成功的工具至关重要。根据利益相关者的意见(如工具部署方式)不断进行修改,以确保该工具对患者和医疗服务提供者都具有实用性和易用性。
实施集成到电子健康记录中的电子新患者入院调查问卷,通过提高患者对问卷的可及性,改善了患者报告结局数据(PRD)的收集,同时还向临床医生和研究人员提供了所有可用数据。对问卷内容和配置的仔细考量使得该工具在全研究所范围内成功实施。
这项工作证明了在全系统实施电子调查问卷的可行性,强调了反复完善以创建一个以患者为中心且临床医生可用的工具的重要性。
电子新患者入院调查问卷能够系统地收集患者报告结局数据,这应通过创新的护理服务和医疗干预措施使癌症护理结果受益。